![](/img/cover-not-exists.png)
Combined Therapeutic Efficacy of the Thymidylate Synthase Inhibitor ZD1694 (TOMUDEX) and the Immunotoxin B43(Anti-CD19)-PAP in a SCID Mouse Model of Human B-Lineage Acute Lymphoblastic Leukemia
Ek, Onur, Reaman, Gregory H., Crankshaw, Daune L., Chelstrom, Lisa M., Myers, Dorothea E., Uckun, Fatih M.Volume:
28
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428199809058358
Date:
January, 1998
File:
PDF, 647 KB
english, 1998